{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:44:12Z","timestamp":1772639052277,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03088"],"award-info":[{"award-number":["22H03088"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K18643"],"award-info":[{"award-number":["19K18643"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03879-8","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:34:20Z","timestamp":1748586860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of galectin-9 in the development of gestational diabetes mellitus"],"prefix":"10.1038","volume":"15","author":[{"given":"Haya Hamed Hassan","family":"Albuayjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Katsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Mise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Oi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BoXuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jota","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Hayata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Masuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"3879_CR1","doi-asserted-by":"crossref","unstructured":"McElwain, C. J., McCarthy, F. P. & McCarthy, C. M. Gestational diabetes mellitus and maternal immune dysregulation: what we know so Far. Int. J. Mol. Sci. 22  (2021).","DOI":"10.3390\/ijms22084261"},{"key":"3879_CR2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1210\/endrev\/bnac003","volume":"43","author":"A Sweeting","year":"2022","unstructured":"Sweeting, A., Wong, J., Murphy, H. R. & Ross, G. P. A clinical update on gestational diabetes mellitus. Endocr. Rev. 43, 763\u2013793 (2022).","journal-title":"Endocr. Rev."},{"key":"3879_CR3","doi-asserted-by":"crossref","unstructured":"Chen, M. et al. Galectins: important regulators in normal and pathologic pregnancies. Int. J. Mol. Sci 23  (2022).","DOI":"10.3390\/ijms231710110"},{"key":"3879_CR4","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1172\/JCI119429","volume":"99","author":"J Wada","year":"1997","unstructured":"Wada, J., Ota, K., Kumar, A., Wallner, E. I. & Kanwar, Y. S. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J. Clin. Invest. 99, 2452\u20132461 (1997).","journal-title":"J. Clin. Invest."},{"key":"3879_CR5","doi-asserted-by":"publisher","first-page":"784473","DOI":"10.3389\/fimmu.2021.784473","volume":"12","author":"E Menkhorst","year":"2021","unstructured":"Menkhorst, E. et al. Medawar\u2019s postera: galectins emerged as key players during Fetal-Maternal glycoimmune adaptation. Front. Immunol. 12, 784473 (2021).","journal-title":"Front. Immunol."},{"key":"3879_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.placenta.2015.07.124","volume":"36","author":"M Meggyes","year":"2015","unstructured":"Meggyes, M. et al. Feto-maternal immune regulation by TIM-3\/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy. Placenta 36, 1153\u20131160 (2015).","journal-title":"Placenta"},{"key":"3879_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1095\/biolreprod.112.105460","volume":"88","author":"R Heusschen","year":"2013","unstructured":"Heusschen, R. et al. Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy. Biol. Reprod. 88, 22 (2013).","journal-title":"Biol. Reprod."},{"key":"3879_CR8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.123.064391","volume":"149","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. A Galectin-9-Driven CD11c(high) decidual macrophage subset suppresses uterine vascular remodeling in preeclampsia. Circulation 149, 1670\u20131688 (2024).","journal-title":"Circulation"},{"key":"3879_CR9","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.3389\/fimmu.2018.03142","volume":"9","author":"ZH Li","year":"2018","unstructured":"Li, Z. H. et al. Galectin-9 alleviates LPS-Induced Preeclampsia-Like impairment in rats via switching decidual macrophage polarization to M2 subtype. Front. Immunol. 9, 3142 (2018).","journal-title":"Front. Immunol."},{"key":"3879_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/cmi.2014.126","volume":"13","author":"YH Li","year":"2016","unstructured":"Li, Y. H. et al. The Galectin-9\/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy. Cell. Mol. Immunol. 13, 73\u201381 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"3879_CR11","doi-asserted-by":"publisher","first-page":"e71811","DOI":"10.1371\/journal.pone.0071811","volume":"8","author":"E Miko","year":"2013","unstructured":"Miko, E. et al. Involvement of Galectin-9\/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia. PLoS One. 8, e71811 (2013).","journal-title":"PLoS One"},{"key":"3879_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejogrb.2015.08.022","volume":"194","author":"H Hao","year":"2015","unstructured":"Hao, H. et al. Upregulation of the Tim-3\/Gal-9 pathway and correlation with the development of preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 194, 85\u201391 (2015).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"3879_CR13","doi-asserted-by":"crossref","unstructured":"Hashemi, E., Malarkannan, S. & Tissue-Resident, N. K. Cells: Development, maturation, and clinical relevance. Cancers (Basel) 12 (2020).","DOI":"10.3390\/cancers12061553"},{"key":"3879_CR14","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.4049\/jimmunol.2001404","volume":"206","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Galectin-9 targets NLRP3 for autophagic degradation to limit inflammation. J. Immunol. 206, 2692\u20132699 (2021).","journal-title":"J. Immunol."},{"key":"3879_CR15","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1038\/s41467-020-18102-7","volume":"11","author":"JN Sudhakar","year":"2020","unstructured":"Sudhakar, J. N. et al. Lumenal Galectin-9-Lamp2 interaction regulates lysosome and autophagy to prevent pathogenesis in the intestine and pancreas. Nat. Commun. 11, 4286 (2020).","journal-title":"Nat. Commun."},{"key":"3879_CR16","doi-asserted-by":"crossref","unstructured":"Pelech, A. et al. Do serum galectin-9 levels in women with gestational diabetes and healthy ones differ before or after delivery? A pilot study. Biomolecules 13 (2023).","DOI":"10.3390\/biom13040697"},{"key":"3879_CR17","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","volume":"6","author":"C Zhu","year":"2005","unstructured":"Zhu, C. et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6, 1245\u20131252 (2005).","journal-title":"Nat. Immunol."},{"key":"3879_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fendo.2019.00198","volume":"10","author":"NM Shah","year":"2019","unstructured":"Shah, N. M., Lai, P. F., Imami, N. & Johnson, M. R. Progesterone-Related immune modulation of pregnancy and labor. Front. Endocrinol. (Lausanne). 10, 198 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"3879_CR19","doi-asserted-by":"publisher","first-page":"728291","DOI":"10.3389\/fimmu.2021.728291","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. & Wei, H. Role of decidual natural killer cells in human pregnancy and related pregnancy complications. Front. Immunol. 12, 728291 (2021).","journal-title":"Front. Immunol."},{"key":"3879_CR20","doi-asserted-by":"publisher","first-page":"679582","DOI":"10.3389\/fendo.2021.679582","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. Transcriptomic profiling of human placenta in gestational diabetes mellitus at the Single-Cell level. Front. Endocrinol. (Lausanne). 12, 679582 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"3879_CR21","doi-asserted-by":"publisher","first-page":"852436","DOI":"10.3389\/fimmu.2022.852436","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang, H., Cao, K., Liu, S., Xu, Y. & Tang, L. Tim-3 expression causes NK cell dysfunction in type 2 diabetes patients. Front. Immunol. 13, 852436 (2022).","journal-title":"Front. Immunol."},{"key":"3879_CR22","doi-asserted-by":"publisher","first-page":"e0147186","DOI":"10.1371\/journal.pone.0147186","volume":"11","author":"J Sun","year":"2016","unstructured":"Sun, J. et al. Tim-3 is upregulated in NK cells during early pregnancy and inhibits NK cytotoxicity toward trophoblast in Galectin-9 dependent pathway. PLoS One. 11, e0147186 (2016).","journal-title":"PLoS One"},{"key":"3879_CR23","doi-asserted-by":"crossref","unstructured":"Arenas-Hernandez, M., Sanchez-Rodriguez, E. N., Mial, T. N., Robertson, S. A. & Gomez-Lopez, N. Isolation of leukocytes from the murine tissues at the Maternal-Fetal interface. J. Vis. Exp., e52866 (2015).","DOI":"10.3791\/52866"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03879-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:34:23Z","timestamp":1748586863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03879-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3879"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03879-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jun Wada receives speaker honoraria from Astra Zeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Kyowa Kirin, Novo Nordisk, and Mitsubishi Tanabe, and receives grant support from Bayer, Chugai, Kyowa Kirin, Otsuka, Shionogi, Sumitomo, and Mitsubishi Tanabe. All other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18981"}}